Loading...

Choose your country and language

You are currently on

Australia

Australia

Overview

Supporting audit-ready compliance through automated HLD with integrated digital traceability solutions

Overview

Supporting audit-ready compliance through automated HLD with integrated digital traceability solutions

Accurate digital records made simple with AcuTrace® technology

To meet local accreditation requirements, traceability processes must be compliant with evidence-based standards and guidelines. The trophon3 device uses AcuTrace radiofrequency identification (RFID) technology to electronically capture high-level disinfection (HLD) data across the reprocessing workflow in accordance with requirements in the USA, CAN, ANZ, UK, and EU .1-13

Automated digital traceability across the disinfection workflow:

  • Simplifies the creation of accurate digital records
  • Increases user compliance
  • Supports audit readiness

AcuTrace-enabled consumables and accessories include:

trophon NanoNebulant®

trophon Chemical Indicator

trophon Operator Card

trophon Medical Instrument Tag

Audit-ready compliance and archiving

AcuTrace technology captures HLD data, which is accessible on your trophon3 device to support audit readiness via different user traceability methods:

  • One-touch logging on your trophon3 device with DICOM worklist integration and optional AuditPro cloud logging
  • Printed labels capturing AcuTrace inputs and disinfection results
  • Downloads of disinfection records to USB

Abbreviations: ANZ, Australia and New Zealand; CAN, Canada; DICOM, Digital Imaging and Communications in Medicine; EU, European Union; HLD, high-level disinfection; RFID, radiofrequency; UK, United Kingdom; USA, United States of America; USB, Universal Serial Bus.

References: 1. AORN 2018. High-Level Disinfection. In: AORN Guidelines for Perioperative Practice. Denver, CO. 2. ANSI/AAMI ST58:2013 Chemical sterilization and high-level disinfection in health care facilities. 3. CDC 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities. 4. AS 5369:2023 Reprocessing of reusable medical devices and other devices in health and non-health related facilities. 5. Australasian Society for Ultrasound in Medicine (ASUM). Australas J Ultrasound Med. 2017;20(1):30–40. 6. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards, second edition. November 2017. 7. CAN/CSA-Z314-18. Canadian Medical Device Reprocessing. February 2018. 8. Health Service Executive. Quality Improvement Division (2017). HSE Guidance for Decontamination of Semi‐critical Ultrasound Probes; Semi‐invasive and Non‐invasive Ultrasound Probes. 9. Health Protection Scotland (2016). NHS Scotland Guidance for Decontamination of Semi-Critical Ultrasound Probes; Semi-invasive and Non-invasive Ultrasound Probes. 10. Welsh Health Technical Memorandum (2014). WHTM 01-06 - Decontamination of flexible endoscopes Part C: Operational management. 11. Department of Health (UK) (2016). Health Technical Memorandum 01-06 Part C Operational management. 12. Ministère des affaires sociales et de la santé (2016). INSTRUCTION N° DGOS/PF2/DGS/VSS1/2016/220 du 4 juillet 2016 relative à relative au traitement des endoscopes souples thermosensibles à canaux au sein des lieux de soins. 13. Kommission für Krankenhaushygiene und Infektionsprävention and Bundesinstitut für Arzneimittel und Medizinprodukte. Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten.

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC